Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer
Abstract Tissue factor (TF) is a protein that plays a critical role in blood clotting, but recent research has also shown its involvement in cancer development and progression. Herein, we provide an overview of the structure of TF and its involvement in signaling pathways that promote cancer cell pr...
Main Authors: | Seyed Esmaeil Ahmadi, Ashkan Shabannezhad, Amir Kahrizi, Armin Akbar, Seyed Mehrab Safdari, Taraneh Hoseinnezhad, Mohammad Zahedi, Soroush Sadeghi, Mahsa Golizadeh Mojarrad, Majid Safa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-06-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40364-023-00504-6 |
Similar Items
-
Recent advances in non-small cell lung cancer targeted therapy; an update review
by: Mahmood Araghi, et al.
Published: (2023-08-01) -
Clinical research progress of targeted therapy combined with immunotherapy for advanced cholangiocarcinoma
by: Qin Liu, et al.
Published: (2023-01-01) -
Targeted Therapies in Advanced Cholangiocarcinoma
by: Michael H. Storandt, et al.
Published: (2023-10-01) -
Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
by: Gail M Wilkes
Published: (2018-01-01) -
Transcription Factors in the Pathogenesis of Lupus Nephritis and Their Targeted Therapy
by: Kasey M. Shao, et al.
Published: (2024-01-01)